Laboratorio Farmaceutico Erfo SpA () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shedir Pharma Group SpA

Pharmanutra SpA

Enervit SpA

Laboratorio Farmaceutico Erfo SpA

Pierrel SpA

Why is Laboratorio Farmaceutico Erfo SpA ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Laboratorio Farmaceutico Erfo SpA for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Laboratorio Farmaceutico Erfo SpA

-100.0%

0.02

46.20%

Italy FTSE MIB

27.29%

1.67

16.34%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

27.12%

EBIT Growth (5y)

-1.70%

EBIT to Interest (avg)

0.39

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

0.67

Tax Ratio

29.30%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

5.19%

ROE (avg)

7.11%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.32

EV to EBIT

10.79

EV to EBITDA

7.49

EV to Capital Employed

1.31

EV to Sales

1.14

PEG Ratio

0.09

Dividend Yield

ROCE (Latest)

6.39%

ROE (Latest)

9.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

DEBTORS TURNOVER RATIO(HY)

Highest at 7.13 times

NET SALES(Q)

At EUR 4.49 MM has Grown at 67.54%

PRE-TAX PROFIT(Q)

At EUR 0.3 MM has Grown at 129.33%

RAW MATERIAL COST(Y)

Fallen by -44.12% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 6.88 times

-7What is not working for the Company

INTEREST(HY)

At EUR 0.03 MM has Grown at 100.18%

NET PROFIT(Q)

Lowest at EUR 0.07 MM

EPS(Q)

Lowest at EUR 0.01

Here's what is working for Laboratorio Farmaceutico Erfo SpA

Net Sales

At EUR 4.49 MM has Grown at 67.54%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (EUR MM)

Pre-Tax Profit

At EUR 0.3 MM has Grown at 129.33%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (EUR MM)

Debtors Turnover Ratio

Highest at 7.13 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Inventory Turnover Ratio

Highest at 6.88 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -44.12% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Laboratorio Farmaceutico Erfo SpA

Interest

At EUR 0.03 MM has Grown at 100.18%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Net Profit

Lowest at EUR 0.07 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (EUR MM)

EPS

Lowest at EUR 0.01

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (EUR)